HomeCompareDACHF vs ARCC

DACHF vs ARCC: Dividend Comparison 2026

DACHF yields 4.16% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DACHF wins by $11.68M in total portfolio value
10 years
DACHF
DACHF
● Live price
4.16%
Share price
$8.44
Annual div
$0.35
5Y div CAGR
71.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.70M
Annual income
$9,653,176.75
Full DACHF calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — DACHF vs ARCC

📍 DACHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDACHFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DACHF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DACHF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DACHF
Annual income on $10K today (after 15% tax)
$353.96/yr
After 10yr DRIP, annual income (after tax)
$8,205,200.24/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, DACHF beats the other by $8,205,199.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DACHF + ARCC for your $10,000?

DACHF: 50%ARCC: 50%
100% ARCC50/50100% DACHF
Portfolio after 10yr
$5.86M
Annual income
$4,826,588.94/yr
Blended yield
82.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

DACHF
No analyst data
Altman Z
2.0
Piotroski
5/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DACHF buys
0
ARCC buys
13
PoliticianChamberTickerTypeAmountDate
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-09-09
John Fetterman🏛 Senate$ARCC▼ Sell$1,001 - $15,0002025-09-04
Ashley Moody🏛 Senate$ARCC▲ Buy$15,001 - $50,0002025-04-04
John Fetterman🏛 Senate$ARCC▲ Buy$1,001 - $15,0002025-02-18
Dave McCormick🏛 Senate$ARCC▲ Buy$250,001 - $500,0002025-01-17
Pete Sessions🏢 House$ARCC▼ Sell$1,001 - $15,0002023-11-01
Pete Sessions🏢 House$ARCC▲ Buy$569.252023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-10-06
Pete Sessions🏢 House$ARCC▲ Buy$155.922023-08-15
Pete Sessions🏢 House$ARCC▲ Buy$0 - $1,0002023-08-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDACHFARCC
Forward yield4.16%10.65%
Annual dividend / share$0.35$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR71.7%-50%
Portfolio after 10y$11.70M$24.5K
Annual income after 10y$9,653,176.75$1.14
Total dividends collected$11.50M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: DACHF vs ARCC ($10,000, DRIP)

YearDACHF PortfolioDACHF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$11,415$715.00$11,373$532.74+$42.00DACHF
2$13,524$1,309.68$12,608$279.46+$916.00DACHF
3$16,960$2,489.85$13,809$142.90+$3.2KDACHF
4$23,158$5,010.66$15,042$72.20+$8.1KDACHF
5$35,758$10,978.76$16,341$36.27+$19.4KDACHF
6$65,464$27,202.50$17,732$18.18+$47.7KDACHF
7$149,960$79,913.86$19,231$9.10+$130.7KDACHF
8$454,211$293,754.32$20,851$4.55+$433.4KDACHF
9$1,913,762$1,427,755.53$22,605$2.28+$1.89MDACHF
10$11,700,902$9,653,176.75$24,504$1.14+$11.68MDACHF

DACHF vs ARCC: Complete Analysis 2026

DACHFStock

Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

Full DACHF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this DACHF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DACHF vs SCHDDACHF vs JEPIDACHF vs ODACHF vs KODACHF vs MAINDACHF vs HTGCDACHF vs GBDCDACHF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.